A shadow market for unapproved weight-loss drugs is being driven by social media fitness personalities and vendors on messaging platforms, based on recent findings.
Experimental Treatment Acquiring Traction Online
The experimental drug, which is still in clinical trials, is being advertised by social media influencers for its supposed weight-reducing properties. Followers are urged to message these accounts directly for supplier links, while also obtaining discount codes.
Active Trade on Social Networks
Additionally, a flourishing trade exists on Telegram, where groups with numerous of participants share “before and after” images, injection guides and assertions of rapid UK delivery. Sellers market the drug there before directing buyers to WhatsApp for transactions.
Learning About The Experimental Drug
Retatrutide is an experimental injection created by American pharmaceutical company Eli Lilly. The drug affects three gut hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could help individuals lose up to a quarter of their body weight. Referred to as the “triple G”, the drug is being hailed online as the next Ozempic.
Healthcare Experts Express Worries
However, doctors and pharmacists have cautions that the distribution of what is still an unlicensed drug in the United Kingdom is worrisome and could lead to individuals injecting products of uncertain source.
Some experts said the demand for retatrutide could be linked to the rising price of licensed weight loss products such as Mounjaro.
Legal Position and Enforcement
Selling retatrutide on TikTok or Telegram is illegal in the United Kingdom, as it is an unapproved drug that must not be marketed or supplied for personal consumption under the British medical regulations.
Some content creators attempt to circumvent the rules by referring to the substance as a “research chemical” or describing it as “not for human consumption”. The substance is not a controlled substance, but promotion and supply can still violate pharmaceutical, advertising, and customer laws, risking fines, prosecution or imprisonment.
Service Reaction and Material Elimination
Based on TikTok, the service has removed violative content and prohibited associated keywords and query recommendations. The organization stated it was dedicated to maintaining the platform secure and investing in enhancing enforcement strategies.
Digital Marketplace Operations
Investigations also found groups with up to 9,000 members marketing retatrutide using Telegram's integrated discovery tool, which operates like a online catalog. Entering “retatrutide” instantly brings up groups with thousands of users, populated with images of weight loss, glowing testimonials and detailed guides for preparing or injecting at home.
After minutes of joining one group, a vendor shared WhatsApp details, where the majority of transactions take place. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When asked whether the substance was authentic, one vendor said: “You can’t be sure.” Another shared a photo of a alleged testing documentation. Not one inquired about weight, health issues or previous experience.
Item Details and Pricing
Inside these communities, messages display dark colored parcels with postal service labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”
Buyers can choose between dry substance containers, prepared at residence with purified liquid, or pre-filled pens usually priced at £160 for 20mg. When questioned how long a pen should last, sellers give contradictory answers varying between a few weeks to “depends on your body”.
Service Oversight and Security Actions
A representative for the messaging service stated it regularly monitored harmful content on its service including content that encouraged the “misuse of controlled medications”. The organization noted that it removed “millions of pieces of harmful content each day”.
Healthcare Expert Cautions
“People are administering substances they can’t verify. Although the research behind retatrutide is valid, these digital versions may not contain what they claim,” said Jason Murphy, the director of pharmaceutical services at Chemist4U.
Dr Crystal Wyllie of Asda Online Doctor linked the increase in demand to current cost increases for authorized slimming medications such as Mounjaro. “With prices rising, individuals are using online platforms. But fake treatments are highly risky. You cannot know what’s inside or whether the conditions they were made in was clean,” she explained.
Her team has already encountered patients harmed by self-injection from unconfirmed suppliers. “We understand the disappointment, but purchasing from Telegram or communication platforms is gambling with your health,” said Wyllie. “These substances could be contaminated or improperly measured.”
Manufacturer Position
A spokesperson from Eli Lilly stated retatrutide was in third stage clinical trials and had not been reviewed or approved by any regulatory agency anywhere in the world. “Therefore at this time no one can sell [it] for human use,” they explained, adding that any product “falsely representing itself as a company investigational substance not yet approved … may expose patients to possibly significant health risks”.
